{"comparisonGroups":["Control_0h","Wounding_72h"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs 72h wounding treatment response","group_a_title":"Control group at time point 0h. Serves as the reference point for all subsequent time points and treatments","group_b_title":"Wounding treatment group at time point 72h. Captures response to wounding treatment at 72h","id":"MTBLS10_0001_00000005","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":2,"studyId":"MTBLS10","studyUrl":"http://integmet.org/study/MTBLS10","title":"Control_0h_vs_Wounding_72h","topHits":[{"chebi_id":"67236","direction":"down","inn_name":"","iupac_name":"(2<i>Z</i>,6<i>E</i>,10<i>E</i>,14<i>S</i>)-14-{[4-<em>O</em>-(6-deoxy-\u03b1-<small>L</small>-mannopyranosyl)-\u03b2-<small>D</small>-glucopyranosyl]oxy}-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraen-1-yl 2-<em>O</em>-\u03b2-<small>D</small>-glucopyranosyl-\u03b2-<small>D</small>-glucopyranoside","metabolite_id":"CWAXZXSFUDEMIX-ZIKBFGBNSA-N","pvalue":0.0001254792416871,"ratio":0.3380945512651232,"synonym_name":""},{"chebi_id":"138000","direction":"down","inn_name":"","iupac_name":"3-(1-methylpyrrolidin-2-yl)pyridine","metabolite_id":"SNICXCGAKADSCV-UHFFFAOYSA-N","pvalue":2.540100536108432e-05,"ratio":0.6227839403747736,"synonym_name":""}],"totalFeatures":7}